Health Care

Larimar Therapeutics, Inc. (LRMR) Stock Score & Signals

Larimar Therapeutics, Inc. (LRMR) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 54 out of 100.

2BB score and signals

Larimar Therapeutics, Inc.’s current 2BB score is 54 out of 100, built from the signal categories below.

Signal	Score	Reading
Activity	60	Moderate
Momentum	66	Improving
Financial strength	15	Very Weak
Quality	80	Very Strong
Risk	44	Moderate

Company facts

Headquarters	Bala Cynwyd, Pennsylvania, United States
Founded	2005
Employees	71
52-week range	$2.72 – $6.42

Recent earnings

Report date	EPS actual	EPS estimate	Revenue actual	Revenue estimate
2026-11-03	—	-0.3938	—	$0.00
2026-08-06	—	-0.3888	—	$0.00
2026-05-14	-0.31	-0.5457	$0.00	$0.00
2026-03-19	-0.73	-0.5171	$0.00	$0.00